• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fonar settles patent dispute with Elscint

Article

MRI developer Fonar has announced that it has resolved its pending patent infringement litigation with Elscint. Terms of the agreement were not released.The deal adds another to the list of companies that have settled MRI patent disputes with Fonar.

MRI developer Fonar has announced that it has resolved its pending patent infringement litigation with Elscint. Terms of the agreement were not released.

The deal adds another to the list of companies that have settled MRI patent disputes with Fonar. Hitachi, Philips, Siemens, Toshiba, and Shimadzu have all reached settlements with them in recent years, while GE lost its legal battle with the firm in 1997, paying a total of $128.7 million (SCAN 7/9/97).

In other Fonar news, the Melville, NY-based company has appointed Sol Ginzburg as vice president of sales. He had recently served as director of international sales for the firm.

Fonar also announced that Pennsylvania Medical Group has acquired another of its Quad 12000 devices for an imaging center in Reading, PA. The group already employs a Quad 12000 scanner at an imaging facility in Philadelphia. Fonar valued the group’s latest purchase at $1.2 million.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.